logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/05/2025
The S&P 500 index futures expanded by 2.8%; Nasdaq 100 index futures rose by 3.5%.
Latest
2 m ago
Kurld Electronics (002121.SZ) plans to sign a trademark licensing agreement with its controlling shareholder Meidi Group.
2 m ago
KoRo Electronics: Plans to sign a trademark licensing agreement with Midea Group.
4 m ago
On May 12, MSD announced that its new carbapenem/enzyme inhibitor compound drug Recarbrio (imipenem/cilastatin) has officially been launched in China for the treatment of infections caused by sensitive gram-negative bacteria in patients 18 years and older. These infections include hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP); complicated urinary tract infections (cUTI), including pyelonephritis, where treatment options are limited or unavailable; and complicated intra-abdominal infections (cIAI) where treatment options are limited or unavailable. The first batch of drugs has been packaged at MSD's factory in Hangzhou, China for its local release.
4 m ago
Merck's new antimicrobial drug Rikobo is being launched on the market in China.
4 m ago
According to reports, Trump's trip to the Middle East will bring back trillions in investments.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.